78
53
Growth Score 78 in past quarter
-10 pts
Heat Score 53 in past quarter
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
527963
Jeil Pharmaceutical is a contributed to the growth and development of the pharmaceutical industry.
- Cho Min-Hee: Director, Clinical Development TeamPast Role: Contera Pharma, Associate Director of Clinical Development Team
- Cho Min-Hee: Head of Clinical Medicine DivisionPast Role: Contera Pharma, Associate Director of Clinical Development Team
About the Company
The Central R&D Center established in 1980 forms the core of the R&D activities of Jeil. Currently, as of 2018, the new drug development laboratory, the pharmacology & toxicology laboratory, the organic synthesis laboratory, the formulation laboratory, and the analysis laboratory are actively engaged in conducting research into the
complete manufacture and ingredients of innovative new drugs, incrementally modified drugs, and generic drugs.